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ABSTRACT
Introduction: Bipolar disorder is a severe and
chronic mental health problem that persists into older
adulthood. The number of people living with this
condition is set to rise as the UK experiences a
rapid ageing of its population. To date, there has
been very little research or service development with
respect to psychological therapies for this group of
people.
Methods and analysis: A parallel two-arm
randomised controlled trial comparing a 14-session,
6-month Recovery-focused Cognitive-Behavioural
Therapy for Older Adults with bipolar disorder
(RfCBT-OA) plus treatment as usual (TAU) versus TAU
alone. Participants will be recruited in the North-West
of England via primary and secondary mental health
services and through self-referral. The primary
objective of the study is to evaluate the feasibility and
acceptability of RfCBT-OA; therefore, a formal power
calculation is not appropriate. It has been estimated
that randomising 25 participants per group will be
sufficient to be able to reliably determine the primary
feasibility outcomes (eg, recruitment and retention
rates), in line with recommendations for sample sizes
for feasibility/pilot trials. Participants in both arms will
complete assessments at baseline and then every
3 months, over the 12-month follow-up period. We
will gain an estimate of the likely effect size of RfCBT-
OA on a range of clinical outcomes and estimate
parameters needed to determine the appropriate
sample size for a definitive, larger trial to evaluate the
effectiveness and cost-effectiveness of RfCBT-OA. Data
analysis is discussed further in the Analysis section in
the main paper.
Ethics and dissemination: This protocol was
approved by the UK National Health Service (NHS)
Ethics Committee process (REC ref: 15/NW/0330). The
findings of the trial will be disseminated through peer-
reviewed journals, national and international conference
presentations and local, participating NHS trusts.
Trial registration number: ISRCTN13875321; Pre-
results.
BACKGROUND
The UK population is ageing and this
pattern is expected to continue into the next
few decades.1 Current estimates suggest that
approximately 10 million people in the UK
are over 65 years old. The latest projections
indicate that there will be 5½ million more
older adults in the UK in 20 years’ time, and
this number will have nearly doubled to 19
million by 2050.2 Consequently the number
of older people living with chronic mental
health problems is also set to rise substan-
tially, including those with bipolar disorder
(BD).3
There is limited research available on the
presentation, course and treatment of BD in
later life. Reasons cited for this lack of infor-
mation include the increased mortality of
younger individuals with BD, sampling biases
in the research studies that are available,
changes in the diagnostic criteria over time
Strengths and limitations of this study
▪ First randomised controlled trial to develop and
test out a psychological intervention for older
adults with bipolar disorder.
▪ Development of a psychological intervention for
a group of people who currently have no
evidence-based care.
▪ Recovery-focused Cognitive Behavioural Therapy
for Older Adults with bipolar disorder
(RfCBT-OA) has been developed in collaboration
partnership with individuals with lived experience
of bipolar disorder.
▪ RfCBT-OA has the potential to improve outcomes
for service users. This would save the National
Health Service (NHS) money through a reduction
in use of mental health services.
▪ No active treatment control arm.
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and differences in research settings where individuals
are studied.4
Available data indicate that rather than early theory
suggestions that BD ‘burns out’,5 the majority of indivi-
duals that experience early onset BD will follow a
chronic and relapsing course into older adulthood.6
Older adults with BD may face additional challenges
such as cognitive impairments7 and a decline in
health-related quality of life.8 9 BD in later life is also
associated with a high risk of suicide10 and signiﬁcant
service costs. Bartels et al11 reports that older adults with
BD utilise almost four times the total use of mental
health services and are four times more likely to be hos-
pitalised and get admitted than older people with uni-
polar depression.
Despite this evidence of the importance of BD in
older adults, there has been very little research or
service development for this group particularly with
respect to psychological therapies.12 The National
Institute for Health and Care Excellence (NICE) BD
guideline13 recommends that older adults should be
offered the same treatment as younger people. However,
there are no published studies evaluating psychosocial
interventions for older adults with BD,14 and a number
of reviews have highlighted the relative paucity of knowl-
edge concerning our knowledge in this area.4 15 16
Although research into psychological therapies for
older adults with BD is lacking, there is evidence for the
effectiveness of such interventions in adults of working
age.3 17 18 Although recovery-informed interventions are
now recommended by the UK government,19 20 much of
the available research to date has focused on cognitive-
behavioural therapy (CBT) and psychoeducational
approaches designed to reduce relapse risk but with
little explicit focus on functional outcomes including
personal recovery. There is no single deﬁnition of ‘recov-
ery’ in mental health. However, it is based on the prin-
ciple that it is possible for an individual to gain a
meaningful life, while living with a serious mental health
problem. Unlike recovery from a physical illness, in
mental health, the person may aim for recovery, while
still experiencing some of the symptoms of their
problem. There is an emphasis on having a set of goals
which may focus on re-establishing other areas in a
person’s life such as their work, relationships or social
life.
A recent randomised controlled trial (RCT) study has
shown that a recovery-focused CBT intervention
(Recovery-focused Cognitive Behavioural Therapy,
RfCBT) for individuals with BD (below 65 years) is bene-
ﬁcial in terms of both functional and symptomatic out-
comes.21 The present trial builds on this work and has
adapted RfCBT, so that it speciﬁcally meets the needs of
an older adult population (RfCBT-OA). Details of how
these adaptations were achieved can be found in the
intervention section.
We therefore intend to perform a RCT to evaluate the
effectiveness and cost-effectiveness of RfCBT-OA plus
treatment as usual (TAU) compared with TAU. However,
there are a number of uncertainties that we need to
address prior to initiating that trial. Therefore, in this
feasibility study, we plan to evaluate the feasibility and
acceptability of the RfCBT-OA intervention and whether
a full RCT is feasible. We will evaluate recruitment into
the study (both self-referral and clinician referral),
consent to participate and participant attrition rates
(overall and each study arm separately) during assess-
ment, intervention and follow-up periods and comple-
tion of outcome measures. We will also be measuring
adherence to the intervention (number of therapy ses-
sions attended, therapy drop out and feedback from
qualitative interviews at the end of therapy). This will
allow us to evaluate the acceptability of the intervention
to the individuals taking part in the study. The trial will
also provide initial data on the potential impact of the
intervention (compared with current routine care) on a
number of clinical outcomes and help to identify the
most appropriate primary outcome (eg, perceived recov-
ery, time to relapse and mood symptoms) for a deﬁnitive
clinical RCT in the future.
METHODS
This protocol is guided by the Standard Protocol Items:
Recommendations for Intervention Trials (SPIRIT) 2013
Guidelines.22 The study is registered with the ISRCTN
registry: ISRCTN13875321. A model consent form is pro-
vided in online supplementary appendix 1.
Objectives
To determine the feasibility and acceptability of a
recovery-focused CBT intervention for older adults with
BD compared with TAU.
The objectives of the study are to:
1. Investigate
A. Whether clinicians working with older adults will
refer participants into a RCT;
B. Whether older adults will self-refer into a RCT;
C. Whether older adults with BD will consent to par-
ticipate in a RCT of a psychological intervention;
D. Participant attrition rates (overall and each study
arm separately) during assessment, intervention
and follow-up periods;
2. Determine the acceptability of the recovery-focused
intervention in terms of
A. Whether individuals adhere to and engage with
the intervention;
B. Participants’ experiences of the intervention;
3. Identify the most appropriate primary outcome
measure (eg, recovery, time to relapse, quality of life)
for a future trial;
4. Estimate parameters needed to determine the appro-
priate sample size for a future trial to evaluate the
effectiveness and cost-effectiveness of RfCBT-OA.
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Trial design
A parallel, two-arm RCT comparing a 14-session,
6-month RfCBT-OA intervention alongside TAU versus
TAU alone. Participants in both arms of the study will
complete assessments which will include a range of
important clinical outcomes (eg, recovery, time to
relapse, quality of life) at baseline and then three
monthly over the 12 month follow-up period (see
ﬁgure 1). Rater blindness will be achieved by having an
independent researcher from the Spectrum Centre
team as ET will deliver the intervention.
A trial steering committee (TSC) will be formed at the
beginning of the trial. It will consist of an independent
chair, independent clinician (s), an independent statisti-
cian, a service user representative and the researcher.
They will meet face to face on four occasions over the
duration of the trial. The TSC will concentrate on pro-
gress of the trial, adherence to the protocol, and import-
antly the rights, safety and well-being of the trial
participants. TSC will review any adverse events should
these occur and will advise on adaptation or termination
of the intervention should this be required.
Sample
Sample size
A formal power calculation is not appropriate as the
primary purpose of the study is to evaluate the feasibility
and acceptability of delivering the proposed interven-
tion. It has been estimated that randomising 25 partici-
pants per group will be sufﬁcient to be able to reliably
determine the primary feasibility outcomes. The recruit-
ment target has been set at 50 participants in line with
recommendations for sample sizes for feasibility/pilot
trials23 and to allow for expected attrition rates (see
table 1). This number will also allow us to evaluate the
other objectives of the trial; to assess the impact of the
intervention on each of the outcome measures; to esti-
mate parameter necessary to design a main trial; and
will enable estimation of recruitment and retention
parameters with sufﬁcient precision. For example,
recruiting 50 participants will enable estimation of the
percentage attrition to within ±10% if attrition is 15% or
less and, if the consent rate is 80%, approaching 63 par-
ticipants and recruiting 50 will enable estimation of the
consent rate to within ±10%.
Inclusion/exclusion criteria
1. A diagnosis of BD (I or II) according to the
Structured Clinical Interview for the Diagnostic and
Statistical Manual of Mental Disorders (SCID)24 IV
research criteria;
2. Not in a current episode of mania, hypomania,
depression or mixed episode in the last month;
3. Aged 65 or above;
4. Sufﬁcient English language skills to comprehend the
assessments and intervention content.
Exclusion criteria:
1. Receiving concurrent psychological therapy;
2. A score of less than 22 on the Montreal Cognitive
Assessment (MoCA).25
Recruitment
Referrals will be sought from participating National
Health Service (NHS) Trusts in the North-West, UK,
with support from the National Institute of Mental
Health (NIHR) Clinical Research Network. This is a
publicly funded national workforce that supports the
recruitment of participants to nationally funded
research studies. The lead researcher will contact man-
agers in older adult community mental health teams,
outpatient clinics, general practitioner (GP) surgeries
and primary care mental health teams. They will request
to attend any planned team meetings and send the par-
ticipant information sheet and referral information for
distribution within the team. The researcher will
follow-up any visits with a phone call and ask the health
professional (eg, psychiatrist, GP, care coordinators) to
complete the referral information sheet and send it via
email or post to the research team. All referrals received
will be recorded on a conﬁdential database and partici-
pants will then be approached to book a screening inter-
view. The researcher will also visit service user groups
(such as Bipolar UK, MIND and Rethink) in the local
area. The researcher will take the study self-referral form
and ask any interested participants to either complete
the form in the group or send it back to the research
team by post or email. Any self-referrals received will be
recorded on a conﬁdential database. The study will also
be advertised through a well-established, conﬁdential
volunteering database at the Spectrum Centre which has
contact details for over 500 individuals that have either
lived experience or an interest in BD as well as through
social media such as Facebook and Twitter and in the
media. Posters and leaﬂets will be distributed in both
NHS and non-NHS sites to maximise participant access.
Screening, baseline and randomisation
Once participants have expressed an interest in partici-
pating, they will be contacted by a member of the
research team to complete a brief screening interview.
The screening interview will be conducted over the tele-
phone and will consist of questions targeting inclusion
and exclusion criteria. The Mood Disorder
Questionnaire (MDQ)26 will also be administered. This
is a brief self-report screening instrument that identiﬁes
individuals likely to have BD. At this stage, all partici-
pants will be asked to provide consent for the researcher
to contact a nominated healthcare professional to
obtain risk-related information (eg, GP, care coordin-
ator). Individuals who meet both the eligibility criteria
and screen likely on the MDQ26 will then be booked in
for an initial assessment.
Assessments will take place at the Spectrum Centre or
the participant’s home, according to preference. If
required, private space for appointments may also be
negotiated at willing primary, secondary and/or
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voluntary organisations. At the initial visit, the study will
be described to potential participants in full. The volun-
tary nature of participation will be emphasised, includ-
ing the right to withdraw at any time.
Information collected during the initial assessment
will be used to conﬁrm eligibility. Once informed
consent is obtained, the baseline assessment will be con-
ducted by the researcher. The MoCA25 will be used as
the ﬁrst screening tool for eligibility as it is the least time
consuming. The MoCA25 assesses for cognitive impair-
ment via multiple cognitive domains including attention,
concentration, executive functions, memory, language,
visuospatial skills, abstraction, calculation and
orientation. If the participant scores 22 or above on the
MoCA,25 then the SCID24 interview will be carried out
to conﬁrm a diagnosis of BD. This will also identify
whether they have had an episode in the past month, to
provide demographic information and assess the
number of previous episodes. Individuals who score
below 22 on the MoCA25 or do not meet the research
criteria for BD will be thanked for their time and
informed that they do not meet the research criteria
required to participate. They will be offered the option
of joining Spectrum Connect (our participant panel),
so that they can ﬁnd out about future research/activities
that may be of greater relevance. If the participant
Figure 1 Flow diagram showing design of the study. RfCBT-OA, Recovery-focused Cognitive Behavioural Therapy for Older
Adults with bipolar disorder; TAU, treatment as usual.
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Table 1 Feasibility outcomes thresholds
Objective Measurement process Feasibility outcome
To estimate the recruitment rate The recruitment rate is set at a
number that is based on the
maximum number of participants that
the therapist can see per month.
However, number of eligible
participants recruited by self-referral
and from each of the sites will be
recorded on a monthly basis. This will
inform the recruitment plan for a
larger trial.
Feasibility will be shown where at
least 3–4 participants are recruited per
month (approximately 50 participants)
over the 15-month recruitment
window.
If at least 2 participants are recruited
per month (approximately 30
participants) or 4–5 participants are
recruited in the past 6 months of the
trial (if recruitment problems are
overcome), then a future trial will be
feasible but additional strategies will
be identified to achieve target
recruitment.
If less than an average of 2
participants are recruited per month
(<25) over the recruitment period,
feasibility will not be demonstrated.
To identify consent rate and
reasons for non-recruitment
Number of referred participants that
are eligible that choose not to consent
into the trial will be recorded and
reasons for refusal will be
documented where offered.
Feasibility will be shown if at least
80% of participants referred (self or
clinician) consent into the trial.
If at least 60% of participants referred
(self or clinician) consent into the trial,
then a future trial will be feasible if
strategies to overcome identified
barriers are identified (including
whether more individuals are
consenting who self-refer or clinician
refer).
If less than 60% of participants
referred do not consent into the trial,
then feasibility will not be
demonstrated.
To estimate the proportion of
participants lost to follow-up and
the reasons for loss to follow-up
The loss of participants during the
follow-up period will be recorded, plus
reasons for loss (if given).
Feasibility will be demonstrated if at
least 70% of participants are retained
at the 48-week follow-up.
If at least 50% or more participants
are retained to follow-up at 48 weeks,
then a future trial will be feasible if
strategies to overcome identified
barriers are identified.
If less than 50% of participants
referred do not consent into the trial,
then feasibility will not be
demonstrated.
To estimate the number of
therapy sessions attended
The number of therapy sessions
attended out of the 14 offered will be
recorded.
Feasibility will be demonstrated if all of
the participants attend 6 or more
sessions of the 14 offered.
If at least 75% of participants attend 6
or more sessions of the 14 offered, a
future trial will be feasible if strategies
to overcome barriers are identified.
If less than 75% of participants do not
take up 6 or more of the therapy
sessions offered, then feasibility will
not be demonstrated.
Continued
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meets criteria and wishes to take part, they will complete
the baseline clinical outcome measures that are detailed
below.
After baseline, the participant will be randomly allo-
cated to either RfCBT-OA or TAU using an independent
web-based computer-generated randomised procedure
(http://www.sealedenvelope.com/) to aid allocation
concealment. The randomisation process will be set up
by Lancashire Clinical Trials Unit (CTU). After random-
isation, the researcher will contact the nominated
healthcare professional to inform them that the partici-
pant is taking part in the study. Intentional unblinding
will only be allowed if necessary for patient safety; any
unintentional unblinding will be recorded (including
reason) and subsequent assessments conducted by
another blind researcher. Data entry procedures and
storage will be overseen by the CTU. All personal infor-
mation will be securely stored in line with NHS ethical
approval.
The recovery-focused CBT intervention
The original RfCBT manual was developed from key
components of effective CBT interventions which
include mood monitoring and awareness, regularisation
of routines, enhancing prodromal coping and
problem-solving training27–31 and reﬁned by qualitative
research to capture experiences of recovery in BD and
through service user focus groups to ensure that the
content, focus and delivery of the intervention was in
tune with service user recovery priorities. The interven-
tion places emphasis on maintaining a very ﬂexible
engagement approach with respect to initial rapport
building and consideration of timing, duration and fre-
quency of sessions. It is focused on helping individuals
work towards goals that are of personal value to them,
whether symptom related or about other areas of their
lives such as work or social support. Initially, the client
and therapist develop a shared understanding of recov-
ery and how working towards the recovery goals may
have a signiﬁcant impact on the individual’s life. The
intervention includes a signiﬁcant formulation compo-
nent, ensuring that any therapeutic approaches are con-
sistent with the client’s current needs.
Recovery-focused therapy32 has the following phases:
1. Introducing the recovery approach to clients;
2. Collection of information about current and histor-
ical mood and functioning;
3. Meaning and relevance of diagnosis;
4. Identiﬁcation of recovery-informed therapy goals;
5. Initial formulation of relationships between mood
experiences and progress towards recovery goals;
6. Identiﬁcation and application of CBT techniques to
address and facilitate positive coping;
7. Consideration of wider functioning issues in relation
to recovery;
8. Development and completion of early warning signs
(EWS) plan;
9. Development and completion of recovery plan;
10. Sharing lessons from therapy with key stakeholders.
Although it is likely that most clients will engage with
most of these elements, the relative emphasis will
depend on the individual goals and formulation of the
particular client. An additional chapter has been devel-
oped for the manual, so that it speciﬁcally meets the
needs of an older adult population. This has been
achieved by a review of current evidence for adapting
psychological interventions for older adults with mental
health problems. There has also been extensive
Table 1 Continued
Objective Measurement process Feasibility outcome
To estimate the number of
participants who drop out of
therapy
The number of participants who drop
out of the therapy sessions will be
recorded.
If at least 65% of the participants in
the intervention arm complete therapy,
then feasibility will be demonstrated.*
If 50% of participant in the intervention
arm complete therapy, then a future
trial will be feasible if strategies to
overcome drop out are identified.
If less than 50% of participants in the
intervention arm drop out of therapy,
then feasibility will not be
demonstrated.
To assess the feasibility of
delivering Rf-CBT-OA in a way
that is acceptable to people with
BD in later life
Interviews with 10–15 participants that
have taken part in the intervention
arm of the study to seek their views
on the therapy.
Feasibility will be demonstrated in the
majority of participants indicate that
the intervention is acceptable.
Red—stop—main study not feasible.
Amber—continue but modify protocol—feasible with modifications.
Green—continue without modifications—feasible as is.
*Based on the percentage of drop out of older adults (33–37%) in comparable studies investigating psychotherapeutic treatment for
depression in later life36–39 psychotherapeutic treatment trials.
BD, bipolar disorder; RfCBT-OA, Recovery-focused Cognitive Behavioural Therapy for Older Adults with BD.
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consultation (focus groups and one-to-one) with service
users with lived experience of BD in later life, their rela-
tives and experts in the ﬁeld.
Data from the focus group have identiﬁed that indivi-
duals living with BD in later life still experience episodes,
however to varying degrees. Some ﬁnd their episodes are
more manageable and the symptoms are less intense,
some feel that they are worse than when they were
younger and are harder to control. Individuals taking
part in the focus group felt that therapy in later life
should focus on psychoeducation, symptom management
and also to consider wider areas of functioning such as
achieving meaningful activity. This ﬁts with the ﬂexible,
idiosyncratic approach that the recovery-focused therapy
offers. The older adults identiﬁed additional difﬁculties
in later life such as physical health problems, memory dif-
ﬁculties key themes such as loneliness, losses and changes
in role. These correspond with the current literature on
adapting psychological therapies for older adults.33 34
Therefore, key areas for adaptation in the new chapter
focus on memory and learning, physical health difﬁcul-
ties and sensory impairments. A number of age-related
themes such as cohort beliefs, role investments, interge-
nerational linkages and the sociocultural context34 are
also discussed as potential areas of adaptation.
Outcomes
Feasibility and acceptability data
To address the primary objective and allow the evalu-
ation of the feasibility and acceptability of delivering the
recovery-focused CBT intervention to older adults with
BD, a number of outcomes will be assessed. Setting
benchmarks for feasibility data will be beneﬁcial to
inform a larger scale assessment of this intervention in
the future.35
Detailed information will be collected which will
include the number of referrals received per month, the
source of recruitment (health professional vs self-
referrals), number of participants contacted, assessed for
eligibility and consented into the trial. Reasons for
non-eligibility or withdrawal of interest will be documen-
ted, where given. Retention of participants in both arms
of the trial will be assessed during assessment, interven-
tion and follow-up periods, and the completion of
outcome measures. Feasibility outcomes will be mea-
sured using detailed thresholds and a trafﬁc light system
described in table 1 below.
To determine the acceptability of the intervention,
quantitative data (eg, number of sessions attended and
drop outs) will be combined with data from a set of
qualitative interviews. These will be conducted to
explore individuals’ experiences of receiving RfCBT-OA
intervention in more detail. A sample (approximately
n=10–15) will take part in a topic-guided qualitative
interview. The sample will be selected purposively across
key characteristics (eg, age, gender, attendance rates) to
create a diverse sample of people which will include
people who completed the intervention and also people
who dropped out. It was felt that this number will
provide sufﬁcient data to provide additional information
for the feasibility outcomes and the acceptability of the
intervention. The interviews will also identify issues and
strategies necessary to inform the design of a larger trial
in the future.
The qualitative data plus the feasibility trial data will
help to allow us to achieve the other objectives of the
study which are to identify the most appropriate primary
outcome measure and to estimate parameters needed to
determine the appropriate sample size for a future trial.
Further details can be found in the Analysis section.
Clinical outcome data
The SCID24 and MoCA25 will be completed at baseline
to conﬁrm the participants’ bipolar diagnosis. The
follow-up period will be 12 months from initial random-
isation. There will be regular 3-month assessments to
evaluate bipolar relapse, bipolar symptoms and function-
ing over the telephone. In addition to this, an assess-
ment of recovery, mood symptoms and quality of life will
be completed at baseline, end of therapy and follow-up
(6 and 12 months). These self-report measures will be
completed either by post or online using participant
preference. See table 2 for assessment measure
schedule.
Interviewer-rated measures
The Structured Clinical Interview for Diagnosis: Research
Version40 provides longitudinal information on
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) episodes (major depression,
mania, hypomania or mixed affective episode). It
includes items from the SCID as well as the Hamilton
Depression Rating Scale (HDRS)41 and Mania Rating
Scale (MRS).42 The SCID-LIFE will be delivered every
3 months over the telephone following baseline to gen-
erate weekly scores of mania and depression on a 1–6
severity scale. Scores of 5/6 indicate presence of symp-
toms and impact on functioning that corresponds to
symptom criteria for major mood episode as deﬁned by
the DSM-IV. Weekly scores will be used to examine the
number of weeks out of episode (a score of 4 or less on
SCID-LIFE), number of weeks without impairment (a
score of 2 or less on SCID-LIFE) and time to ﬁrst
episode of depression and mania.
Personal and Social Performance Scale43: The Personal
and Social Performance Scale (PSP) is an interview
schedule to assess functioning in the domains of socially
useful activities, personal and social relationships, self-
care, and disturbing and aggressive behaviours. Good
inter-rater reliability has been reported.43 It has been
used previously to assess outcome in response to treat-
ment for BD.22
Self-report outcome measures
The Bipolar Recovery Questionnaire (BRQ)44 is a self-report
measure designed to assess personal experiences of
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recovery in BD. The BRQ is scored out of 3600 (a
higher score indicates a higher degree of self-rated
recovery). The BRQ is internally consistent and reliable
over test-retest period.44 There is also evidence that the
BRQ is sensitive to change in a recovery-focused CBT
trial for early BD.22
The Internal State Scale (ISS)45 is a 15-item self-report
measure that assesses symptoms of mania and depres-
sion. It compromises of four subscales: activation, per-
ceived conﬂict, well-being and depression. Each
statement is rated based on how the individual has felt
in the past 24 h. A cut-off score of >200 on activation
scale has been validated as indicative of the presence of
(hypo)mania when accompanied by a score of >125 on
the well-being scale.45
The Centre for Epidemiologic Studies Depression Scale
(CES-D)46 is a 20-item self-administered scale designed to
measure depressive symptoms in the general population.
The scale measures the major components of depressive
symptomatology, including depressive mood, feelings of
guilt and worthlessness, psychomotor retardation, loss of
appetite, and sleep disturbance. Each item is scored on
a four-point Likert scale to determine a level of severity
score: <15 (no depression); 15–21 (mild-to-moderate
depression); >21 (possibility of major depression).
Work and Social Adjustment Scale (WSAS)47 is a brief
ﬁve-item measure of functioning in the domains of
work, home management, social leisure, private leisure
and relationships. There is a maximum score of 40 (a
higher score indicates higher severity of difﬁculties). It
has been extensively used in longitudinal research on
BD.48 49
The WHO Quality of Life Scale (WHOQOL-Bref )50 com-
prises of 26 items, which measure the following broad
domains: physical health, psychological health, social
relationships and environment. The scores from the
four domains are transformed on a scale from 0 to 100.
Quality Of Life in Bipolar Disorder Scale (QoL.BD)51 is a
12-item disorder-speciﬁc questionnaire used to assess
quality of life in BD within several areas including phys-
ical, sleep, mood, leisure, spirituality and identity. The
QoL.BD is scored out of 60 (a higher score indicates
higher perceived quality of life). Initial ﬁeld testing of
the quality of life in BD supports use of the instrument
as a feasible, reliable and valid disorder-speciﬁc quality
of life measure for BD.51
Measures to assess therapeutic alliance
The Working Alliance Inventory—Short form, therapist and
client version (WAI-S)52 is a 12-item questionnaire that
measures the strength of the therapeutic alliance
between both therapist and client. The WAI-S measures
three dimensions of alliance: bond, goals and tasks. Two
versions of the WAI-S will be used; one speciﬁc for the
client, and one for the therapist, both of which will be
administered twice across the 14 therapy sessions. The
WAI-S has received psychometric support, has good
overall internal consistency (α=0.94), and good internal
consistency for each dimension of alliance, including
bond (α=0.84), goals (α=0.88) and tasks (α=0.90).
ANALYSIS
Feasibility
The key focus of the trial is on issues of feasibility and
acceptability of the intervention. Much of the analysis
will therefore be based around summary statistics used
to estimate key parameters: rates of recruitment, demo-
graphics of sample, and retention to therapy and
follow-up assessments. These summary statistics will be
accompanied by 95% CIs.
Clinical outcomes
In line with recommendations for sample sizes for feasi-
bility/pilot trials,5 obtaining outcome data from at least
80%20 participants per group will be sufﬁcient to
address key objectives (such as the estimation of the SD
of a quantitative outcome or the proportion with a
dichotomous outcome) with adequate precision.
Generalised linear mixed models will be used to assess
the impact of the intervention on each of the continu-
ous outcome measures to estimate parameters necessary
to design the main trial. Time to ﬁrst relapse will be ana-
lysed using time-to-event methods, including
Kaplan-Meier estimation and the Cox proportional
hazards regression model. Separate analyses will be per-
formed for the three different types of recurrence (any,
depressive and hypomanic/manic episodes). Analyses
will be conducted on an intention-to-treat basis and key
parameter estimates will be presented as point estimates
with 95% CIs.
A number of factors will be analysed to help identify a
primary clinical outcome for a main trial (eg, recovery,
time to relapse and mood symptoms). Each measure will
be assessed in relation to its sensitivity to change, com-
pletion rates and acceptability which will be explored
further during the qualitative interviews.
Qualitative data
Data from qualitative interviews will be analysed using a
process called thematic analysis53 54 which focuses on
examining themes in the data and identifying implicit
and explicit ideas. The qualitative transcripts will be
read and coded using a coding frame that will be devel-
oped as the data analysis progresses. The codes will be
organised into thematic headings and the data will be
reordered and summarised into themes. The analysis
will be crosschecked by another member of the research
team to ensure validity.
Dissemination plans
The team intend to publish the outcomes from the trial
in peer-reviewed journals but will also try to reach public
audiences including people living with BD through
third sector events and contributions to third section
publications as well as use of social media. No
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professional writers will be used and all authors will con-
tribute substantively to ﬁnal manuscripts.
DISCUSSION
This study aims to develop and test the feasibility and
acceptability of the RfCBT-OA intervention for older
people living with BD. The data from the trial will allow
us to determine rates of recruitment and retention and
identify factors which may help improve these rates if a
future trial is feasible. The acceptability of the thera-
peutic intervention will be assessed by evaluating the
therapy attendance rates, drop outs and feedback from
the qualitative interviews. We will also be able to gain an
estimate of the likely effect size of RfCBT-OA on a range
of clinical outcomes. All of these data are essential to
inform the design of a large-scale trial. Detailed feasibil-
ity outcome thresholds have been set in table 1. These
will need to be met in order to progress to a further,
deﬁnitive evaluation trial of the clinical and cost-
effectiveness of RfCBT-OA.
The original recovery intervention, RfCBT,32 was devel-
oped in collaboration partnership with individuals with
lived experience of BD. This included service user
involvement in qualitative work on recovery experiences
and a structure and format of the RfCBT intervention.
As highlighted by Jones et al,32 engaging individuals with
personal experience of BD at this level ﬁts with the
model of recovery approaches as being empowering,
individualised and grounded in the individual’s own pri-
orities and needs. The current RfCBT-OA intervention
has been further reﬁned by a group of older adults
living with BD and experts in the ageing ﬁeld.
Strengths of the study include the development of an
intervention for a group of people who currently have
no evidence-based care. The Department of Health55
states that older adults with mental health problems
should have access to the same range of therapies as
those people under the age of 65. This is not the case
for people with BD. There are currently no published
studies evaluating psychological interventions for older
adults with BD and there is a clear need to develop an
evidence base for this population.
The rapid ageing of the population will make signiﬁ-
cant demands on healthcare services, especially if the
current lack of evidence-based treatments continues.
The development of a recovery-focused psychological
intervention has the potential to improve outcomes for
service users, helping them to develop a range of coping
strategies and putting them more in control of man-
aging their mental health problems. This would save the
NHS money through a reduction in use of mental
health services. The intervention also offers a ﬂexibility
to work on a range of outcomes. Focus group work with
this population has identiﬁed that individuals are still
experiencing episodes in later life and want the ﬂexibil-
ity to work on both symptom management and other
areas of their life. The recruitment for the study will
take place across primary and secondary mental health
services and through self-referral. There is the hope that
not restricting recruitment to specialist mental health
services will allow a more representative sample.
There are a number of limitations to the study. First,
there is no active treatment control arm, so any indica-
tions that the intervention is effective may not be specif-
ically related to the recovery-focused intervention per se.
Second, the scale of the study allows a follow-up period
of only 6 months following therapy. A longer follow-up
period might have been more helpful to assess the
impact of the intervention and whether individuals
would complete assessment measures over a longer time
period. However, the primary aim of the study is to
assess the feasibility and acceptability of the intervention;
therefore, the 6-month follow-up window is a ﬁrst
Table 2 Assessment schedule
Follow-up period (weeks)
Measure Baseline face to face 12 Phone 24 Phone Postal/online 36 Phone 48 Phone Postal/online
SCID *
MoCA *
SCID-LIFE * * * * *
HDRS * * * * *
MRS * * * * *
PSP * * * * *
BRQ * * *
ISS * * *
CES-D * * *
WSAS * * *
WHOQoL-Bref * * *
QoL.BD * * *
CES-D, Centre for Epidemiologic Studies Depression Scale; HDRS, Hamilton Depression Rating Scale; ISS, Internal State Scale; MoCA,
Montreal Cognitive Assessment; MRS, Mania Rating Scale; PSP, Personal and Social Performance Scale; QoL.BD, Quality Of Life in Bipolar
Disorder Scale; SCID, Statistical Manual of Mental Disorders; WHOQoL-Bref, WHO Quality of Life Scale; WSAS, Work and Social Adjustment
Scale.
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appropriate step to help to assess whether a further,
deﬁnitive RCT is feasible in the future. Third, as this is
the ﬁrst intervention study for older adults with BD,
there are no well-validated measures for this population.
The bipolar-related measures have not yet been speciﬁc-
ally validated for use with an older adult population.
However, the samples for the development papers for
the BRQ44 and the QoL.BD51 included people over the
age of 60. Additionally, focus group data indicate that
outcomes such as personal recovery and quality of life
are still important over the age of 60.
Despite these limitations, if this intervention is feasible
to deliver, it offers a promising step for a group of
people that currently does not have access to evidence-
based psychological care.
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